Anti-sense trefoil factor family-3 (intestinal trefoil factor) inhibits cell growth and induces chemosensitivity to adriamycin in human gastric cancer cells

被引:34
作者
Chan, MWY
Chan, VYW
Leung, WK
Chan, KK
To, KF
Sung, JJY
Chan, FKL
机构
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China
关键词
ITF; gastric cancer; adriamycin;
D O I
10.1016/j.lfs.2004.11.014
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Intestinal trefoil factor (ITF), which is normally absent in gastric mucosa, is over-expressed in gastric cancer. However, the functional significance of ITF in gastric cancer is unknown. We examined the effects of blocking ITF expression on the growth of gastric cancer cells and their responses to chemotherapeutic agents. Anti-sense ITF cDNA was cloned into mammalian expression vector pcDNA3 and was transfected into an ITF-expressing gastric cancer cell line SNU-1. We assessed the doubling time and anchorage dependent growth of the transfected cells using growth curve and soft agar assay respectively. Cell cycle analysis and apoptosis were determined by flow cytometry and cell death ELISA. The response to chemotherapeutic agents after transfecting anti-sense ITF was also examined. Anti-sense ITF transfectant (3A-5) had a significantly longer doubling time as compared to control cells which were transfected with empty vector (32.4 hr vs 26.9 hr, p < 0.05). In the soft agar assay, 3A-5 formed fewer colonies than control (3.5 colonies vs 23.5 colonies, p < 0.05). Although there was no significant difference in the cell cycle distribution between 3A-5 and control, anti-sense ITF resulted in marked increase in adriamycin-induced apoptosis. Our results demonstrated that blocking the expression of ITF inhibits growth of gastric cancer cells and enhances the response to chemotherapy. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:2581 / 2592
页数:12
相关论文
共 47 条
[1]   Gastroprotective peptide trefoil factor family 2 gene is activated by upstream stimulating factor but not by c-Myc in gastrointestinal cancer cells [J].
Al-azzeh, E ;
Dittrich, O ;
Vervoorts, J ;
Blin, N ;
Gött, P ;
Lüscher, B .
GUT, 2002, 51 (05) :685-690
[2]   Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor [J].
Beck, PL ;
Wong, JF ;
Li, Y ;
Swaminathan, S ;
Xavier, RJ ;
Devaney, KL ;
Podolsky, DK .
GASTROENTEROLOGY, 2004, 126 (03) :796-808
[3]   Adriamycin (ADM) induced apoptosis in transitional cell cancer (TCC) cell lines accompanied by p21(WAF1/CIP1) induction [J].
Bilim, VN ;
Tomita, Y ;
Kawasaki, T ;
Takeda, M ;
Takahashi, K .
APOPTOSIS, 1997, 2 (02) :207-213
[4]  
Bottero V, 2001, CANCER RES, V61, P7785
[5]  
Chan Victor Y., 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P332
[6]   TREFOIL PEPTIDES PROMOTE EPITHELIAL MIGRATION THROUGH A TRANSFORMING GROWTH-FACTOR BETA-INDEPENDENT PATHWAY [J].
DIGNASS, A ;
LYNCHDEVANEY, K ;
KINDON, H ;
THIM, L ;
PODOLSKY, DK .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :376-383
[7]   Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells [J].
Efstathiou, JA ;
Noda, M ;
Rowan, A ;
Dixon, C ;
Chinery, R ;
Jawhari, A ;
Hattori, T ;
Wright, NA ;
Bodmer, WF ;
Pignatelli, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (06) :3122-3127
[8]   Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells [J].
Emami, S ;
Le Floch, N ;
Bruyneel, E ;
Thim, L ;
May, F ;
Westley, B ;
Rio, MC ;
Mareel, M ;
Gespach, C .
FASEB JOURNAL, 2001, 15 (02) :351-361
[9]   MEDICAL PROGRESS - GASTRIC-CARCINOMA [J].
FUCHS, CS ;
MAYER, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) :32-41
[10]   Cisplatin biochemical mechanism of action:: From cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways [J].
Fuertes, MA ;
Castilla, J ;
Alonso, C ;
Pérez, JM .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (03) :257-266